share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director MEYER MELODY B

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director MEYER MELODY B

艾伯维公司 | 4：持股变动声明-董事 MEYER MELODY B
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心信息
On May 3, 2024, Melody B. Meyer, reported a completed transaction involving the acquisition of 1,322 shares of AbbVie Inc. common stock at no cost. The transaction was classified as a grant. Following this transaction, Meyer's direct holdings in AbbVie Inc. increased to a total of 15,295 shares of common stock. The transaction reflects a continued investment in the company by Meyer, with the shares acquired directly indicating a vested interest in the company's performance.
On May 3, 2024, Melody B. Meyer, reported a completed transaction involving the acquisition of 1,322 shares of AbbVie Inc. common stock at no cost. The transaction was classified as a grant. Following this transaction, Meyer's direct holdings in AbbVie Inc. increased to a total of 15,295 shares of common stock. The transaction reflects a continued investment in the company by Meyer, with the shares acquired directly indicating a vested interest in the company's performance.
2024年5月3日，Melody B. Meyer报告了一项已完成的交易，涉及免费收购艾伯维公司1322股普通股。该交易被归类为赠款。在这笔交易之后，迈耶在艾伯维公司的直接持股量增加到总共15,295股普通股。该交易反映了迈耶对该公司的持续投资，收购的股票直接表明了公司业绩的既得利益。
2024年5月3日，Melody B. Meyer报告了一项已完成的交易，涉及免费收购艾伯维公司1322股普通股。该交易被归类为赠款。在这笔交易之后，迈耶在艾伯维公司的直接持股量增加到总共15,295股普通股。该交易反映了迈耶对该公司的持续投资，收购的股票直接表明了公司业绩的既得利益。
有用
没用

该公告为独立文件：

独立文件1

独立文件2

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息